Eleven Therapeutics’ Post

Excellent study! The findings are insightful and well-presented. Great work!

Molecules of the Month - June Edition In this edition of Molecules of the Month, LCC are excited to announce our updated and improved Fragment Library. Find out how LCC's 3D-rich, stereo-defined, novel Fragment Library can accelerate your drug discovery programmes. 👇 #FBDD #DrugDiscovery

o2h discovery's commitment to excellence in scientific research is exemplified by our recent investment in the FLIPR Penta technology. We stand ready to collaborate seeking FLIPR-based assay services for different drug discovery programs. The introduction of the FLIPR Penta High-Throughput Cellular Screening System to our repertoire, enables rapid screening of compound libraries and to assess the effects of potential drug candidates in a fast, automated, and precise manner. It has extensive use in understanding GPCR and ion channel biology. With the simultaneous pipette and read function, plus high-end camera system, we can allow up to 100 measurements per second and provide detailed information about cardiomyocyte and/or neuronal  oscillations. We offer multiple fluorescence or luminescence-based assay readouts, and can support in measuring calcium flux, potassium and membrane potential. To know more about our biology service please visit - https://lnkd.in/dFQdm2z6 or write us at discovery@o2h.com Partner and speak with our biologists to tailor your research needs, and let us contribute to the advancement of your drug discovery initiatives. #o2hdiscovery #BiologyCapabilities #DrugDiscovery #BiologyServices #SeedingNewIdeas #LifeScience #Biotech #GPCR #ionchannels #assaydevelopment #research #biology

The PanOmics TargetID Framework – a modular system designed to assist clients in achieving their R&D goals – is an integral part of Evotec’s drug discovery program. PanOmics is the overarching term used to refer to the analysis of multiple data sets obtained from clinical studies and related biomedical sources. The TargetID Framework uses computational tools coupled with expert assessments to identify and rank potential drug targets based on their disease-relevance, druggability, biology, safety, competition, and efficacy. Being fully integrated into Evotec's drug discovery pipeline, it enables the client to leverage additional work packages and/or omics data, to aid the transition from target identification to IND. Download our whitepaper to find out more - https://hubs.ly/Q02dfwLB0 #researchneverstops

The Biophysical Society Annual Meeting BPS2024 is in full swing, and the energy here is incredible! From February 10th to February 14th (February 10th to February 14th) ( https://lnkd.in/gzzqSVrz). We're immersed in a dynamic atmosphere, surrounded by fellow members of the scientific community eager to explore the latest advancements in biophysics. At Booth 918, you'll find us buzzing with excitement, ready to engage and connect with everyone who stops by. It's fantastic to see our friends at MiTeGen, stationed at Booth 718. Our partnership with MiTeGen is invaluable; they're a cornerstone in our industry, providing essential supplies for protein crystallography, microscopes, Cryo-EM grid supplies, and more (www.mitegen.com). Together, we're part of a thriving community dedicated to pushing the boundaries of scientific discovery. Let's make the most of this opportunity to learn, collaborate, and inspire each other. See you at the conference! Did you know... Here at Helix, we're dedicated to pushing the limits of crystallography and structure determination services! By seamlessly integrating cutting-edge lab technology, expert scientific knowledge, and advanced computational software, we're committed to producing results that are truly exceptional. Our passion? Ensuring nothing less than excellence for each and every one of our esteemed clients. So, why delay? Call us! (www.helixbiostructures.com) #cryoem #crystallization #crystallography #drugdiscovery #drugdesign #protein #proteins #dna #rna #antibody #antibodies #science #nature #research #bio #bionetwork #biotechnology #biotech #bioscience #biotechnologyindustry #biopharma #drugdesign #drugdevelopment #pharmaceuticals #pharma #drug #lifesciences #lifescience

Stimulating innovative research! Topics: * Discovery strategies for molecular glue degraders and other protein-protein-interaction stabilizers - 1 grant comprising up to 100,000 €/year for up to 3 years with potential further collaboration *Augmented Reality Digital Twin - 1 grant comprising up to 120,000 €/year for 1 year with potential further collaboration *AI-Driven Drug Discovery – up to 3 grants comprising AIDDISON software licenses for one year with potential further collaboration Application deadline August 31st!

The PanOmics TargetID Framework – a modular system designed to assist clients in achieving their R&D goals – is an integral part of Evotec's drug discovery program. PanOmics is the overarching term used to refer to the analysis of multiple data sets obtained from clinical studies and related biomedical sources. The TargetID Framework uses computational tools coupled with expert assessments to identify and rank potential drug targets based on their disease-relevance, druggability, biology, safety, competition, and efficacy. Being fully integrated into Evotec's drug discovery pipeline, it enables the client to leverage additional work packages and/or omics data, to aid the transition from target identification to IND. Download our whitepaper to find out more - https://hubs.ly/Q02dfx8D0 #researchneverstops

Since 2018, we are offering a series of #research grants to stimulate #innovative research in challenging areas of future importance. Grants of up to 500,000 € per year for up to 3 years have been made available. In 2024, grants are available in the area as further specified below. 🟣#Discovery strategies for molecular glue #degraders and other protein-protein-interaction stabilizers - 1 grant comprising up to 100,000 €/year for up to 3 years with potential further collaboration 🟡Augmented Reality #Digital Twin - 1 grant comprising up to 120,000 €/year for 1 year with potential further #Collaboration 🔵#AI Driven #DrugDiscovery – up to 3 grants comprising AIDDISON software licenses for one year with potential further collaboration For more detail pl. visit: https://lnkd.in/gSuQ_4Uu Hurry up! Submission deadline 31 August 2024 #merckresearchgrants #curioousopprtunityboard #drugdiscovery #medicines #medicinalchemistry #drugdevelopment #innovation #scienceandtechnology #researchanddevelopment #Researchers #Professors #Universities #ChemicalBiology Merck Healthcare Merck KGaA, Darmstadt, Germany Merck Group Ulrich Betz

Target identification is a fundamental first step in #drugdiscovery involving the discovery and validation of disease-associated molecular mechanism that can be modulated by a drug. In this whitepaper we introduce Evotec’s PanOmics TargetID Framework developed by our #computationalbiology and #bioinformatics teams.

The PanOmics TargetID Framework – a modular system designed to assist clients in achieving their R&D goals – is an integral part of Evotec's drug discovery program. Find out what my colleague Sven Sauer and his team published. #researchneverstops #panomics #panhunter